TailorMed CEO Srulik Dvorsky to Lead Panel Session on the Impact of Technology on Specialty Pharmacy Affordability Programs at NASP 2025 Conference
Discussion Will Explore How Emerging Innovations Can Lead to Improved Clinical and Financial Outcomes

New York, September 3, 2025 — TailorMed, a leading healthcare technology company, announced that co-founder and chief executive officer Srulik Dvorsky will moderate a panel session on patient affordability initiatives during the National Association of Specialty Pharmacy (NASP) 2025 Annual Meeting & Expo at the Gaylord Resort in Denver, Colorado. The conference takes place September 14-17, 2025. Dvorsky’s session, “Leveraging Technology to Scale Affordability Programs in Specialty Pharmacy,” will take place on September 14 at 10:10 a.m. MT.
During the session, Dvorsky will be joined by leaders from CenterWell, Prime Therapeutics, and Alivia Health. The panelists will examine how technology is improving access to financial assistance for specialty treatments, resulting in better patient outcomes, operational efficiency, and pharmacy performance.
"Despite the many financial assistance programs available, finding and enrolling patients in these resources is often manual and time-consuming, leading to treatment delays and abandonment,” said Dvorsky. “This panel session will educate attendees on how pharmacies can streamline and automate affordability workflows, improving adherence, elevating care quality, and increasing revenue.”
TailorMed’s expansive network brings together leading pharmacies, providers, life science companies, and other stakeholders to broaden access to financial resources. Since its inception, the company has secured more than $5 billion in financial assistance for patients.
TailorMed representatives will be available throughout the conference at booth #426 for discussions and demonstrations of their affordability solutions.
To learn more about TailorMed, please visit https://tailormed.com/.
{{boilerplate}}
{{tailormed-contact}}
{{pr-contact}}
About TailorMed
TailorMed is the medication success platform removing every barrier across the patient medication journey, from access and affordability through adherence and ongoing care. Through a connected network spanning 945+ hospitals, 4,700+ clinics, 3,100+ pharmacies, 100+ life sciences programs, and 6,000+ support programs, TailorMed has supported over 75 million patients and secured more than $7.4 billion in financial assistance since 2020. TailorMed's platform, including TailorMed Core, TailorMed Connect, TailorMed Complete, TailorMed Amplify, and TailorMed Alliance, connects patients, providers, pharmacies, and life sciences companies through one coordinated network designed to reach every patient at every step of their medication journey. Learn more at tailormed.com.
Media Contacts:
Jennifer Martin, VP, Marketing
jenm@tailormed.co
PR Contacts:
Glenn Goldberg
Parallel Communications Group
+1 516 776-3282
𝕏: @Parallel_PR
LinkedIn
ggoldberg@parallelpr.com